The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A two-part phase 2 randomized study of dalantercept and axitinib versus placebo plus axitinib in advanced renal cell carcinoma: Results from the part 1 dose escalation cohorts.
Michael B. Atkins
Consultant or Advisory Role - Acceleron Pharma
Martin Henner Voss
Honoraria - Novartis
Research Funding - Bristol-Myers Squibb; Pfizer
Elizabeth R. Plimack
No relevant relationships to disclose
Brian I. Rini
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; immatics; Merck; Pfizer; Roche
Robert Alter
Consultant or Advisory Role - Algeta; Astellas/Medivation; Bayer; Bristol-Myers Squibb; Dendreon; Janssen
Honoraria - Amgen; Astellas/Medivation; Bayer/Algeta; Dendreon; Pfizer; Teva
Nancy Ann Dawson
Consultant or Advisory Role - Pfizer
J. Thaddeus Beck
No relevant relationships to disclose
Rupal Satish Bhatt
Consultant or Advisory Role - Acceleron Pharma
Research Funding - Acceleron Pharma
Kristen M. Pappas
Employment or Leadership Position - Acceleron Pharma
Dawn Wilson
Employment or Leadership Position - Acceleron Pharma
Stock Ownership - Acceleron Pharma
Ty McClure
Consultant or Advisory Role - Acceleron Pharma
Stock Ownership - Acceleron Pharma
Ravi Kumar
Employment or Leadership Position - Acceleron Pharma
Stock Ownership - Acceleron Pharma
Kenneth M. Attie
Employment or Leadership Position - Acceleron Pharma
Stock Ownership - Acceleron Pharma
Matthew L. Sherman
Employment or Leadership Position - Acceleron Pharma
Stock Ownership - Acceleron Pharma
Shuchi Sumant Pandya
Employment or Leadership Position - Acceleron Pharma
Stock Ownership - Acceleron Pharma